Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b

被引:37
作者
Bernet, J [1 ]
Mullick, J [1 ]
Panse, Y [1 ]
Parab, PB [1 ]
Sahu, A [1 ]
机构
[1] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
基金
英国惠康基金;
关键词
D O I
10.1128/JVI.78.17.9446-9457.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The vaccinia virus complement control protein (VCP) is an immune evasion protein of vaccinia virus. Previously, VCP has been shown to bind and support inactivation of host complement proteins Cab and Cob and to protect the vaccinia virions from antibody-dependent complement-enhanced neutralization. However, the molecular mechanisms involved in the interaction of VCP with its target proteins Cab and Cob have not yet been elucidated. We have utilized surface plasmon resonance technology to study the interaction of VCP with Cab and Cob. We measured the kinetics of binding of the viral protein to its target proteins and compared it with human complement regulators factor H and sCR1, assessed the influence of immobilization of ligand on the binding kinetics, examined the effect of ionic contacts on these interactions, and sublocalized the binding site on Cab and Cob. Our results indicate that (i) the orientation of the ligand is important for accurate determination of the binding constants, as well as the mechanism of binding; (ii) in contrast to factor H and sCR1, the binding of VCP to Cab and Cob follows a simple 1:1 binding model and does not involve multiple-site interactions as predicted earlier; (iii) VCP has a 4.6-fold higher affinity for Cob than that for Cab, which is also reflected in its factor I cofactor activity; (iv) ionic interactions are important for VCP-C3b and VCP-C4b complex formation; (v) VCP does not bind simultaneously to Cab and Cob; and (vi) the binding site of VCP on C3b and C4b is located in the C3dg and C4c regions, respectively.
引用
收藏
页码:9446 / 9457
页数:12
相关论文
共 55 条
[11]   Humoral response to herpes simplex virus is complement-dependent [J].
Da Costa, XJ ;
Brockman, MA ;
Alicot, E ;
Ma, MH ;
Fischer, MB ;
Zhou, XN ;
Knipe, DM ;
Carroll, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12708-12712
[13]  
Fischer MB, 1996, J IMMUNOL, V157, P549
[14]   Virus subversion of immunity: a structural perspective [J].
Gewurz, BE ;
Gaudet, R ;
Tortorella, D ;
Wang, EW ;
Ploegh, HL .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (04) :442-450
[15]   SUPPRESSION OF THE IMMUNE-RESPONSE BY A SOLUBLE COMPLEMENT RECEPTOR OF LYMPHOCYTES-B [J].
HEBELL, T ;
AHEARN, JM ;
FEARON, DT .
SCIENCE, 1991, 254 (5028) :102-105
[16]   Solution structure and dynamics of the central CCP module pair of a poxvirus complement control protein [J].
Henderson, CE ;
Bromek, K ;
Mullin, NP ;
Smith, BO ;
Uhrín, D ;
Barlow, PN .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (01) :323-339
[17]   INVIVO INHIBITION OF THE ANTIBODY-RESPONSE BY A COMPLEMENT RECEPTOR SPECIFIC MONOCLONAL-ANTIBODY [J].
HEYMAN, B ;
WIERSMA, EJ ;
KINOSHITA, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (02) :665-668
[18]   VACCINIA VIRUS COMPLEMENT-CONTROL PROTEIN PREVENTS ANTIBODY-DEPENDENT COMPLEMENT-ENHANCED NEUTRALIZATION OF INFECTIVITY AND CONTRIBUTES TO VIRULENCE [J].
ISAACS, SN ;
KOTWAL, GJ ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :628-632
[19]   Poxvirus immunomodulatory strategies: Current perspectives [J].
Johnston, JB ;
McFadden, G .
JOURNAL OF VIROLOGY, 2003, 77 (11) :6093-6100
[20]  
Jokiranta TS, 2000, J BIOL CHEM, V275, P27657